Definium Therapeutics, Inc.
DFTXMedicinal Chemicals & Botanical Products · SIC 2833 · CIK 0001813814
Revenue FY2025
—
Net Income
$(184.0M)
EPS (Basic)
$-2.06
Net Margin
—
ROE
-55.3%
Total Equity
$332.0M
Shares Out
134M
Definium Therapeutics, Inc. — Medicinal Chemicals & Botanical Products. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 9 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Platinum Investment Management
Platinum Investment Management
$3.3M
0.8%
—
RA Capital Management
RA Capital Management
$70.6M
0.4%
NEW
Duquesne Family Office
Stanley Druckenmiller
$16.8M
0.4%
NEW
OrbiMed Advisors
OrbiMed Advisors
$17.2M
0.1%
(54.6%)
Royce & Associates
Royce & Associates
$9.8M
0.1%
(10.9%)
Holocene Advisors
Holocene Advisors
$37.5M
0.1%
(27.1%)
Adage Capital Management
Adage Capital Management
$47.0M
0.1%
(13.0%)
Capital World Investors
Capital World Investors
$252.5M
0.0%
NEW
Alps Advisors
Alps Advisors
$5.2M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…